ABSTRACT
INTRODUCTION: Homeopathic remedies usually contain a significant amount of ethanol as a co-solvent with water, a pharmaceutical formulation that may raise some concern when remedies are tested in vitro or in laboratory animals, due to the assessed toxicity of ethanol on cell cultures and organisms. The amount of alcohol in a homeopathic remedy is adjusted following the different homeopathic pharmacopoeias but it is rarely below 30% v/v, which is a molar mass established to meet both Hahnemann's traditional heritage and the hypothetical role of ethanol in "imprinting" water, through the formation of nanobubbles, with the homeopathic activity of the remedy. AIMS: This article aims at discussing the role of ethanol in homeopathic dilutions and how its chemical nature should affect the experimental approach in homeopathy. ISSUES UNDER DEBATE: While the content of ethanol in a homeopathic remedy should be as low as 20% v/v, which is a molar fraction able to catalyze the formation of nanobubbles in a dynamized alcohol-water dilution, this amount raises concern about ethanol toxicology in the experimental research with laboratory animals or in vitro. Several authors diluted 1:100 ethanol 30% v/v from their tested homeopathic dilutions with distilled water to prevent the cytotoxic effect of the alcohol, but in doing so, they probably reduced the ability of ethanol (now 0.3% v/v) to induce the formation of nanobubbles, thus probably affecting the homeopathic property of the same dilution. This may generate concerns about how to manage an experimental setting, to meet both the "chemical" nature of ethanol and its role in "homeopathy," an issue that is discussed in the article. CONCLUSION: Any author working with homeopathic dilutions containing a molar fraction of ethanol higher than 20% should take into account the fact that ethanol is cytotoxic and may be a catalyst to the formation of nanobubbles, and so should adjust the experimental approach accordingly.
Subject(s)
Ethanol , Homeopathy/methods , Materia Medica/chemistry , Solutions/chemistry , Solvents/chemistry , Animals , Complex Mixtures/chemistry , Humans , Solutions/analysisABSTRACT
The major objection to homeopathic medicine is that the doses of medicine prescribed in some cases are too dilute for any active ingredient to be present. The medicines would hence be rendered inactive, necessitating novel explanations for the action. A further examination of dilution in the light of the Langmuir equation shows that homeopathic medicines may not be as dilute as a simplistic application of Avogadro's Principle suggests, due to surface effects.
Subject(s)
Homeopathy , Indicator Dilution Techniques , Nanoparticles/analysis , Water/chemistry , Calibration , Humans , Luminescent Measurements/methods , Mathematics , Reproducibility of Results , Solutions/analysisABSTRACT
BACKGROUND: Influenza viruses cause highly contagious acute respiratory illnesses with significant mortality, especially among young children, elderly people, and individuals with serious medical conditions. This encourages the development of new treatments for human flu. Biotherapies are diluted solutions prepared from biological products compounded following homeopathic procedures. OBJECTIVES: To develop a biotherapy prepared from the infectious influenza A virus (A/Aichi/2/68 H3N2) and to verify its in vitro response. METHODS: The ultradiluted influenza virus solution was prepared in the homeopathic dilution 30dH, it was termed Influenzinum RC. The cellular alterations induced by this preparation were analyzed by optical and electron microscopy, MTT and neutral red assays. Glycolytic metabolism (PFK-1) was studied by spectrophotometric assay. Additionally, the production of tumor necrosis factor-α (TNF-α) by J774.G8 macrophage cells was quantified by ELISA before and after infection with H3N2 influenza virus and treatment. RESULTS: Influenzinum RC did not cause cytotoxic effects but induced morphological alterations in Madin-Darby canine kidney (MDCK) cells. After 30 days, a significant increase (p < 0.05) in mitosis rate was detected compared to control. MDCK mitochondrial activity was changed after treatment for 10 and 30 days. Treatment significantly diminished (p < 0.05) PFK-1 activity. TNF-α in biotherapy-stimulated J774.G8 macrophages indicated a significant (p < 0.05) increase in this cytokine when the cell supernatant was analyzed. CONCLUSION: Influenzinum RC altered cellular and biochemical features of MDCK and J774G8 cells.
Subject(s)
Homeopathy/methods , Influenza A Virus, H3N2 Subtype/physiology , Animals , Biological Therapy , Cell Line/virology , Dogs , Indicator Dilution Techniques , Macrophages/metabolism , Microscopy, Electron , Mitosis , Phosphofructokinase-1/metabolism , Solutions/analysis , Spectrophotometry , Tumor Necrosis Factor-alpha/metabolismABSTRACT
Homeopathy is controversial because medicines in high potencies such as 30c and 200c involve huge dilution factors (106° and 104°° respectively) which are many orders of magnitude greater than Avogadro's number, so that theoretically there should be no measurable remnants of the starting materials. No hypothesis which predicts the retention of properties of starting materials has been proposed nor has any physical entity been shown to exist in these high potency medicines. Using market samples of metal-derived medicines from reputable manufacturers, we have demonstrated for the first time by Transmission Electron Microscopy (TEM), electron diffraction and chemical analysis by Inductively Coupled Plasma-Atomic Emission Spectroscopy (ICP-AES), the presence of physical entities in these extreme dilutions, in the form of nanoparticles of the starting metals and their aggregates.
Subject(s)
Homeopathy , Indicator Dilution Techniques , Luminescent Measurements/methods , Microscopy, Electron, Transmission/methods , Nanoparticles/analysis , Solutions/analysis , Calibration , Humans , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Reproducibility of Results , Solutions/chemistry , Thermoluminescent Dosimetry , Water/chemistryABSTRACT
BACKGROUND: Homeopathic drugs even with dilutions beyond 10(23) (high potencies) are frequently used, although their working mechanism is still unknown. Curative information preserved in solvent structure is postulated to exert biologic effects. OBJECTIVE: The objective was to test for a stimulating or inhibiting effect of high potencies of the homeopathic remedy HgCl2 (Mercurius corrosivus) on two sugar hydrolases. METHODS: High potencies were produced using stepwise dilution plus shaking. Controls included potentized solvent (aqua bidestillata), equimolar dilutions without shaking, and enzyme-free references. Tested were potencies with dilution factors 1:200 (CC) on diastase extract from winter barley, and 1:100 (C) on alpha-amylase from hog pancreas. Enzyme activity was colorimetrically determined by Lugol's iodine-starch reaction. RESULTS: An inhibiting effect of HgCl2 on enzyme activities was observed only in low potencies and dilutions. Statistically significant differences between potencies and controls were not found in randomized and blinded experiments. CONCLUSIONS: This experimental design provided independent reproducible results of cell-free in vitro assays. However, it did not indicate an effect of potentized HgCl2 on hydrolases. Demonstrating potency effects may require additional experimental features.
Subject(s)
Amylases/drug effects , Homeopathy/methods , Mercuric Chloride/pharmacology , Solutions/analysis , alpha-Amylases/drug effects , Analysis of Variance , Chemistry, Pharmaceutical , Dose-Response Relationship, Drug , Drug Compounding/methods , In Vitro Techniques , Mercury Compounds/pharmacology , Reproducibility of Results , Research Design/standardsABSTRACT
Pancuronium bromide (PCBr), a neuro-muscular blocking agent, was determined quantitatively in aqueous solution by ion-pair extraction. Separate determination of PCBr and degradation products was possible after thin layer chromatography. The procedure was developed by using a theoretical approach. Favorable conditions were calculated from the ion-pair extraction constant. The drug was determined with bromothymol blue at pH 9.0, using one extraction in the direct procedure and 2 successive extractions in the combined elution-extraction process after thin layer chromatography. In the direct method, 0.100 mg PCBr was determined with a reproducibility of +/- 1.0%.